Meeder Asset Management Inc X Biotech Inc. Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$15.65 - $19.92 $86,153 - $109,659	-5,505 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$13.97 - $21.16 $1,383 - $2,094	-99 Reduced 1.77%	5,505 $105,000
Q2 2020 Aug 11, 2020	BUY	$10.39 - $16.07 $21,143 - $32,702	2,035 Added 57.02%	5,604 $76,000
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $12,641 - $35,464	1,422 Added 66.23%	3,569 $39,000
Q4 2019 Feb 13, 2020	BUY	$8.33 - $19.95 $17,884 - $42,832	2,147 New	2,147 $40,000
Q4 2017 Feb 02, 2018	SELL	$3.9 - $4.66 $690 - $824	-177 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$4.14 - $5.12 $732 - $906	177	177 $1,000

4.9M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $102M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.